Abridge Raises $250M Series D

Leading gen-AI platform for clinical conversations, has raised a $250 million Series D investment, co-led by Elad Gil and IVP. Abridge has been deployed in more than 100 of the largest and most complex health systems in the United States.

Major drugmakers are planning to meet with President Donald Trump this week at the White House as part of the industry’s effort to work with the new administration.

The Australian startup builds AI-enabled medical diagnostic software and services to analyze CT scans, X-rays, and pathology slides for radiologists and medical examiners.

Candid Health simplifies medical billing by automating claims submissions and eliminating manual work for billing teams. The team is not using Gen AI, and leans on machine learning.

“Being good in business is the most fascinating kind of art”. A doctor and unicorn founder, Shiv Rao’s career is in many ways a testament to the value of branching out.

The deadly cancer is often not found until it has spread to other parts of the body.

Clinicians and patients need innovation and AI.